Back to Search
Start Over
Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke
- Source :
- Circulation, vol 133, iss 6
- Publication Year :
- 2016
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2016.
-
Abstract
- Background— The effect of intensive blood pressure (BP) lowering on kidney function among individuals with established cerebrovascular disease and preserved estimated glomerular filtration rate (eGFR) is not established. Methods and Results— Among 2610 participants randomized to a lower (30%) using linear mixed models and logistic regression, respectively. We assessed associations of both treatment and kidney function decline with stroke, major vascular events, and the composite of stroke, death, major vascular events, or myocardial infarction using multivariable Cox regression, separately and jointly including a test for interaction. Analyses were conducted by treatment arm. Mean age was 63±11 years; 949 participants (36%) were diabetic; and mean eGFR was 80±19 mL·min −1 ·1.73 m −2 . At 9 months, achieved systolic BP was 137±15 versus 127±14 mm Hg in the higher versus lower BP group, and differences were maintained throughout follow-up (mean, 3.2 years). Compared with the higher target, the lower BP target had a −0.50–mL·min −1 ·1.73 m −2 per year (95% confidence interval [CI], −0.79 to −0.21) faster eGFR decline. Differences were most pronounced during the first year (−2.1 mL·min −1 ·1.73 m −2 ; 95% CI, −0.97 to −3.2), whereas rates of eGFR decline did not differ after year 1 (−0.095; 95% CI, −0.47 to 0.23). A total of 313 patients (24%) in the lower BP group had rapid kidney function decline compared with 247 (19%) in the higher BP group (odds ratio, 1.4; 95% CI, 1.1–1.6). Differences in rapid decline by treatment arm were apparent in the first year (odds ratio, 1.4; 95% CI, 1.1–1.8) but were not significant after year 1 (odds ratio, 1.0; 95% CI, 0.73–1.4). Rapid decline was associated with higher risk for stroke, major vascular events, and composite after full adjustment among individuals randomized to the higher BP target (stroke hazard ratio, 1.93; 95% CI, 1.15–3.21) but not the lower BP arm (stroke hazard ratio, 0.93; 95% CI, 0.50–1.75; all P for interaction Conclusions— In patients with prior lacunar stroke and relatively preserved kidney function, intensive BP lowering was associated with a greater likelihood of rapid kidney function decline. Differences were observed primarily during the first year of antihypertensive treatment. Rapid kidney function decline was not associated with increased risk for clinical events among those undergoing intensive BP lowering. Clinical Trial Registration— URL: http://www.clinicalTrials.gov . Unique identifier: NCT00059306.
- Subjects :
- Male
Kidney Disease
Blood Pressure
Cardiorespiratory Medicine and Haematology
030204 cardiovascular system & hematology
Kidney
Cardiovascular
law.invention
0302 clinical medicine
Randomized controlled trial
Lacunar
law
Secondary Prevention
030212 general & internal medicine
Myocardial infarction
Stroke
cerebrovascular disorders
Middle Aged
stroke
Treatment Outcome
Combination
Public Health and Health Services
Cardiology
Platelet aggregation inhibitor
Drug Therapy, Combination
Female
Cardiology and Cardiovascular Medicine
Glomerular Filtration Rate
kidney
medicine.medical_specialty
hypertension
Lacunar stroke
Clinical Trials and Supportive Activities
Clinical Sciences
Renal and urogenital
Renal function
Article
03 medical and health sciences
Drug Therapy
Double-Blind Method
Clinical Research
Physiology (medical)
Internal medicine
medicine
Humans
Aged
Proportional hazards model
business.industry
Blood Pressure Determination
medicine.disease
Brain Disorders
Surgery
Blood pressure
Cardiovascular System & Hematology
Stroke, Lacunar
business
Platelet Aggregation Inhibitors
Follow-Up Studies
Subjects
Details
- ISSN :
- 15244539 and 00097322
- Volume :
- 133
- Database :
- OpenAIRE
- Journal :
- Circulation
- Accession number :
- edsair.doi.dedup.....0f8d7bf636435827e30011f620a09b02